Fatty Liver Treatment Market - Forecast(2019 - 2024)

Report Code: HCR 0211 Report Format: PDF + Excel (Delivery in 48 Hrs)
Fatty liver disease is one of the most common liver dysfunction where the triglyceride fat accumulates in liver cells. The major causes of fatty liver disease are obesity and excessive alcohol consumption. The major risks associated with fatty liver disease are alcoholic cirrhosis, cardiovascular disorder, metabolic syndrome and biliary cirrhosis among others. It is expected to be one of the leading causes of hepatocellular carcinoma.

The technological advancements and the routine liver function tests have increased the detection of fatty liver disease in the early stage. The increase in incidence of fatty liver disease associated with excessive alcohol intake is expected to create an opportunity for the treatment market during the forecast period. The market for overall fatty liver treatment is expected to grow significantly owing to the availability of a variety of agents for fatty liver treatment. However, the market growth can be restrained owing to the side effects associated with the treatment, coupled with stringent regulatory requirements.

This report identifies the global fatty Liver Treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global fatty Liver Treatment market.
 
Fatty Liver Treatment Market

Geographically, North America is estimated to hold the largest share in the fatty liver treatment market. Asia-Pacific is estimated to witness the highest growth during the forecast period in the fatty liver treatment market owing to rising drug and alcohol abuse coupled with increasing incidences of lifestyle related diseases. 

This report segments fatty Liver Treatment market on the basis of drug, end-use, and regional market as follows:
  • Fatty Liver Treatment Market, by Drug: Thiazolidinedione, Vitamin E, Metformin Statins, Polyunsaturated fatty acids, Angiotensin receptor blockers,  and Pentoxifylline
  • Fatty Liver Treatment Market, by End-Use: Hospitals and Clinics
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region.

Sample Companies Profiled in this Report are:
  • Cardax, Inc.
  • Daewoong Co., Ltd.
  • Hoffmann-La Roche Ltd.
  • Glenmark
  • GW Pharmaceuticals
  • 10+
1. Fatty Liver Treatment Market –Overview
2. Executive Summary 
3. Fatty Liver Treatment Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Fatty Liver Treatment Market–Forces
   4.1. Drivers
      4.1.1. Cost Effective Treatment Procedures
      4.1.2. Advancement in Technology
   4.2. Restraints
      4.2.1. Side-Effects
   4.3. Opportunities
      4.3.1. Increasing Incidence of Alcohol Related Diseases
   4.4.  Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Fatty Liver Treatment Market, By Drug 
   5.1. Thiazolidinedione
   5.2. Vitamin E
   5.3. Metformin
   5.4. Statins
   5.5. Polyunsaturated fatty acids
   5.6. Angiotensin receptor blockers
   5.7. Pentoxifylline
6. Fatty Liver Treatment Market, By End-Use 
   6.1. Hospitals
   6.2. Clinics
7. Fatty Liver Treatment Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America 
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Fatty Liver Treatment – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles
   9.1. Cardax, Inc.
      9.1.1. Introduction
      9.1.2. Financials
      9.1.3. Key Insights
      9.1.4. Key Strategy
      9.1.5. Product Portfolio
      9.1.6. SWOT Analysis
   9.2. Daewoong Co., Ltd.
      9.2.1. Introduction
      9.2.2. Financials
      9.2.3. Key Insights
      9.2.4. Key Strategy
      9.2.5. Product Portfolio
      9.2.6. SWOT Analysis
   9.3. Hoffmann-La Roche Ltd.
      9.3.1. Introduction
      9.3.2. Financials
      9.3.3. Key Insights
      9.3.4. Key Strategy
      9.3.5. Product Portfolio
      9.3.6. SWOT Analysis
   9.4. Glenmark
      9.4.1. Introduction
      9.4.2. Financials
      9.4.3. Key Insights
      9.4.4. Key Strategy
      9.4.5. Product Portfolio
      9.4.6. SWOT Analysis
   9.5. GW Pharmaceuticals
      9.5.1. Introduction
      9.5.2. Financials
      9.5.3. Key Insights
      9.5.4. Key Strategy
      9.5.5. Product Portfolio
      9.5.6. SWOT Analysis
   9.6. Limerick BioPharma, Inc.
      9.6.1. Introduction
      9.6.2. Financials
      9.6.3. Key Insights
      9.6.4. Key Strategy
      9.6.5. Product Portfolio
      9.6.6. SWOT Analysis
   9.7. Merck & Co., Inc.
      9.7.1. Introduction
      9.7.2. Financials
      9.7.3. Key Insights
      9.7.4. Key Strategy 
      9.7.5. Product Portfolio
      9.7.6. SWOT Analysis
   9.8. Novartis AG
      9.8.1. Introduction
      9.8.2. Financials
      9.8.3. Key Insights
      9.8.4. Key Strategy
      9.8.5. Product Portfolio
      9.8.6. SWOT Analysis
   9.9. Orchid Chemicals & Pharmaceuticals Ltd
      9.9.1. Introduction
      9.9.2. Financials
      9.9.3. Key Insights
      9.9.4. Key Strategy
      9.9.5. Product Portfolio
      9.9.6. SWOT Analysis
   9.10. AstraZeneca
      9.10.1. Introduction
      9.10.2. Financials
      9.10.3. Key Insights
      9.10.4. Key Strategy
      9.10.5. Product Portfolio
      9.10.6. SWOT Analysis
*More than 10 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
List of Tables:

Table1: Fatty Liver Treatment Market Overview 2019-2024
Table2: Fatty Liver Treatment Market Leader Analysis 2018-2019 (US$)
Table3: Fatty Liver Treatment Market Product Analysis 2018-2019 (US$)
Table4: Fatty Liver Treatment Market End User Analysis 2018-2019 (US$)
Table5: Fatty Liver Treatment Market Patent Analysis 2013-2018* (US$)
Table6: Fatty Liver Treatment Market Financial Analysis 2018-2019 (US$)
Table7: Fatty Liver Treatment Market Driver Analysis 2018-2019 (US$)
Table8: Fatty Liver Treatment Market Challenges Analysis 2018-2019 (US$)
Table9: Fatty Liver Treatment Market Constraint Analysis 2018-2019 (US$)
Table10: Fatty Liver Treatment Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table11: Fatty Liver Treatment Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table12: Fatty Liver Treatment Market Threat of Substitutes Analysis 2018-2019 (US$)
Table13: Fatty Liver Treatment Market Threat of New Entrants Analysis 2018-2019 (US$)
Table14: Fatty Liver Treatment Market Degree of Competition Analysis 2018-2019 (US$)
Table15: Fatty Liver Treatment Market Value Chain Analysis 2018-2019 (US$)
Table16: Fatty Liver Treatment Market Pricing Analysis 2019-2024 (US$)
Table17: Fatty Liver Treatment Market Opportunities Analysis 2019-2024 (US$)
Table18: Fatty Liver Treatment Market Product Life Cycle Analysis 2019-2024 (US$)
Table19: Fatty Liver Treatment Market Supplier Analysis 2018-2019 (US$)
Table20: Fatty Liver Treatment Market Distributor Analysis 2018-2019 (US$)
Table21: Fatty Liver Treatment Market Trend Analysis 2018-2019 (US$)
Table22: Fatty Liver Treatment Market Size 2018 (US$)
Table23: Fatty Liver Treatment Market Forecast Analysis 2019-2024 (US$)
Table24: Fatty Liver Treatment Market Sales Forecast Analysis 2019-2024 (Units)


List of Figures:

Figure 1: Overview of Fatty Liver Treatment Market 2019-2024
Figure 2: Market Share Analysis for Fatty Liver Treatment Market 2018 (US$)
Figure 3: Product Comparison in Fatty Liver Treatment Market 2018-2019 (US$)
Figure 4: End User Profile for Fatty Liver Treatment Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Fatty Liver Treatment Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Fatty Liver Treatment Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Fatty Liver Treatment Market 2018-2019
Figure 8: Ecosystem Analysis in Fatty Liver Treatment Market 2018
Figure 9: Average Selling Price in Fatty Liver Treatment Market 2019-2024
Figure 10: Top Opportunites in Fatty Liver Treatment Market 2018-2019
Figure 11: Market Life Cycle Analysis in Fatty Liver Treatment Market
Figure 12: GlobalBy Drug Fatty Liver Treatment Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy End UseFatty Liver Treatment Market Revenue, 2019-2024 ($)
Figure 14: Global Fatty Liver Treatment Market - By Geography
Figure 15: Global Fatty Liver Treatment Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global Fatty Liver Treatment Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 18: US Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 60: U.K Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 93: China Fatty Liver Treatment Market Value & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Fatty Liver Treatment Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Fatty Liver Treatment Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Fatty Liver Treatment Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Fatty Liver Treatment Market
Figure 131: Developments, 2018-2019*Fatty Liver Treatment Market
Figure 132: Company 1 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Fatty Liver Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Fatty Liver Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Fatty Liver Treatment Market Net Sales Share, By Geography, 2018 (%)